MARKHAM, Ontario, Dec. 15, 2017 — Sienna Senior Living Inc. (“Sienna” or the “Company”) (TSX:SIA) today announced a dividend of $0.075 per common share of the Company (each, a “Common Share”) for the month of December 2017, representing $0.90 per Common Share on an annualized basis.
The dividend will be payable on January 15, 2018 to shareholders of record as at December 29, 2017. The Company's dividends are designated as eligible dividends for Canadian tax purposes in accordance with subsection 89(14) of the Income Tax Act (Canada), and any applicable corresponding provincial and territorial legislation.Sienna has a Dividend Reinvestment Plan (the “DRIP”) which allows eligible shareholders of the Company to direct that their cash dividends be reinvested in additional Common Shares. Common Shares issued pursuant to the DRIP are issued from treasury at a 3% discount from the market price. Participation in the DRIP is optional and shareholders who do not wish to participate in the plan will continue to receive cash dividends. A complete copy of the DRIP is available under the Investors section of the Company’s website.ABOUT SIENNA SENIOR LIVINGSienna Senior Living is a leading seniors’ living provider with 75 residences in key markets in Canada. Sienna offers a full range of seniors’ living options, including independent and assisted living, long-term care, and specialized programs and services. Sienna also provides expert management services. Sienna is committed to national growth, while driving long-term value for shareholders. The company’s more than 11,000 employees are passionate about helping residents live fully every day, and were the driving force behind Sienna being named one of Canada’s Most Admired Corporate Cultures in 2017. For more information, please visit www.siennaliving.ca.CONTACT:Nitin Jain
Chief Financial Officer & Chief Investment Officer
Latest posts by Sarah Thompson (see all)
- "Unbanned: The Legend of AJ1" Tells True Story of the Original Air Jordan, the Shoe that Defied Everything - February 18, 2018
- New Data in Pediatric Patients with Axillary Hyperhidrosis Presented During Late-Breaking Research Forum at the 76th Annual Meeting of the American Academy of Dermatology - February 17, 2018
- AbbVie Presents New Late-Breaking Phase 2b Data on Upadacitinib in Atopic Dermatitis at the 2018 American Academy of Dermatology Annual Meeting - February 17, 2018